Good Samaritan Hospital of Suffern Chemical Dependency Unit/Rehab
-
Services:
- Sign language services for the deaf and hard of hearing
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Substance use treatment
- Smoking not permitted
- Male
- Female
- Hepatitis education, counseling, or support
- Smoking/vaping/tobacco cessation counseling
- Individual counseling
- Group counseling
- Substance use disorder education
- Family counseling
- Health education services other than HIV/AIDS or hepatitis
- HIV or AIDS education, counseling, or support
- State Substance use treatment agency
- Drug Enforcement Agency (DEA)
- The Joint Commission
- Hospital licensing authority
- State department of health
- Young Adults
- Adults
- This facility administers/prescribes medication for alcohol use disorder
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- Testing for Hepatitis C (HCV)
- STD testing
- Breathalyzer or blood alcohol testing
- HIV testing
- Drug or alcohol urine screening
- Metabolic syndrome monitoring
- TB screening
- Testing for Hepatitis B (HBV)
- Medicare
- Medicaid
- Federal military insurance (e.g., TRICARE)
- State-financed health insurance plan other than Medicaid
- Cash or self-payment
- Private health insurance
- No formal relationship with prescribing entity
- Private non-profit organization
- General Hospital (including VA hospital)
- Outcome follow-up after discharge
- Discharge Planning
- Aftercare/continuing care
- Naloxone and overdose education
- Prescribes naltrexone
- Maintenance service with medically supervised withdrawal after stabilization
- Relapse prevention with naltrexone
- Accepts clients using MAT but prescribed elsewhere
- Buprenorphine maintenance
- Prescribes buprenorphine
- No formal relationship with prescribing entity
- Substance use disorder counseling
- Motivational interviewing
- Relapse prevention
- Trauma-related counseling
- 12-step facilitation
- Cognitive behavioral therapy
- Brief intervention
- Suicide prevention services
- Case management service
- Mental health services
- Early intervention for HIV
- Domestic violence services, including family or partner
- Screening for tobacco use
- Screening for substance use
- Complete medical history/physical exam
- Screening for mental disorders
- Outreach to persons in the community
- Comprehensive substance use assessment
- Comprehensive mental health assessment
- Hospital inpatient treatment
- Hospital inpatient/24-hour hospital inpatient
- Buprenorphine used in Treatment
- Naltrexone used in Treatment
- Vaping not permitted
- Medication for mental disorders
- Nicotine replacement
- Acamprosate (Campral®)
- Clonidine
- Medications for HIV treatment
- Buprenorphine without naloxone
- Naltrexone (oral)
- Non-nicotine smoking/tobacco cessation
- Naltrexone (extended-release, injectable)
- Buprenorphine with naloxone
- Mentoring/peer support
- Recovery coach
- Assistance with obtaining social services
- Self-help groups
Language Services
Type of Care
Facility Smoking Policy
Gender Accepted
Education and Counseling Services
License/Certification/Accreditation
Age Groups Accepted
Type of Alcohol Use Disorder Treatment
Testing
Payment/Insurance/Funding Accepted
External Source of Medications Used for Alcohol Use Disorder Treatment
Facility Operation (e.g., Private, Public)
Hospitals
Transitional Services
Type of Opioid Treatment
External Opioid Medications Source
Treatment Approaches
Ancillary Services
Assessment/Pre-treatment
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Opioid Medications used in Treatment
Facility Vaping Policy
Pharmacotherapies
Recovery Support Services